Home/Filings/4/0001723128-19-000097
4//SEC Filing

Bhadauria Pradeep 4

Accession 0001723128-19-000097

CIK 0001723128other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:59 PM ET

Size

5.0 KB

Accession

0001723128-19-000097

Insider Transaction Report

Form 4
Period: 2019-05-15
Bhadauria Pradeep
SVP, Chief Scientific Officer
Transactions
  • Purchase

    Class A Common Stock

    2019-05-15$8.48/sh+7,000$59,3607,500 total
Footnotes (1)
  • [F1]The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.30 per share to $8.55 per share. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc., any security holder of Amneal Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Amneal Pharmaceuticals, Inc.

CIK 0001723128

Entity typeother

Related Parties

1
  • filerCIK 0001774812

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:59 PM ET
Size
5.0 KB